Podcasts about rsv vaccine

In this episode, Jewel Mullen, MD, MPH, MPA, and Dallas Nelson, MD, CMD, FACP discuss overcoming barriers to RSV vaccine uptake in post-acute and long-term care facilities, including:How to incorporate the latest RSV vaccination recommendations into clinical practicePractical strategies for navigating insuranceEffective and empathetic methods of addressing vaccine hesitancy.  Presenters:Jewel Mullen, MD, MPH, MPAAssociate Dean for Health EquityAssociate Professor of Population Health and Internal MedicineUniversity of Texas at Austin Dell Medical SchoolAustin, TexasDallas Nelson, MD, CMD, FACPProfessor of MedicineDivision of Geriatrics and AgingUniversity of RochesterMedical DirectorUR Medicine Geriatrics GroupRochester, New YorkLink to full program: https://bit.ly/4lrwa5uFollow along with the slides: https://bit.ly/3RdWAKeGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

What's the new long COVID study? How bad is this year's flu? How many measles vaccines do you need? What food has been recalled? When to get RSV vaccine pregnancy? AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses the ongoing flu season, 2025 measles outbreak news, a new study on long COVID in women, uptake of maternal RSV vaccines, as well as food recalls and financial challenges faced by rural healthcare facilities. American Medical Association CXO Todd Unger hosts.

In episode 594, Mike and James invite Samantha Moe back to talk about the use of the RSV vaccine in pregnancy. The only way to have an informed conversation around this vaccine is to know the numbers. If you listen to the whole podcast, you'll get all the numbers available to date. Show notes Tools for Practice 1)Bumpin' Up the Protection? RSV Vaccine in Pregnancy 2) Preventing RSV Infections in Infants 3) Preventing RSV in the elderly

The RSV vaccine during pregnancy has just been approved for use in Australia and the Australian government is providing it for free to all pregnant women. Mel goes over the research about the vaccine's effectiveness and the results of the 3 studies done so far. There is limited short term data but no long term data since this is a new vaccine. Melanie is a registered Midwife and so is required by her registration body to uphold the recommendations in the Australian National Immunisations Handbook. Melanie is also required to use current evidence to inform practice. Mel is preparing resources for the education of her own clients and has offered this here to assist women and other health practitioners understand the research behind this new vaccine. Get more from the Great Birth Rebellion Podcast Join the podcast mailing list to access the resource folder from each episode at www.melaniethemidwife.com Join the rebellion and show your support! Grab your Great Birth Rebellion merchandise now at www.thegreatbirthrebellion.com Follow us on social media @thegreatbirthrebellion and @melaniethemidwife or watch this podcast on Youtube here If this podcast has improved your knowledge or pregnancy, birth or postpartum journey please consider thanking us financially by donating to support the ongoing work of this podcast. Disclaimer The information and resources provided on this podcast does not, and is not intended to, constitute or replace medical or midwifery advice. Instead, all information provided is intended for education, with its application intended for discussion between yourself and your care provider and/or workplace if you are a health professional. The Great Birth Rebellion podcast reserves the right to supplement, edit, change, or delete any information at any time. Whilst we have tried to maintain the accuracy and completeness of information, we do not warrant or guarantee the accuracy or currency of the information. The podcast accepts no liability for any loss, damage or unfavourable outcomes howsoever arising out of the use or reliance on the content. This podcast is not a replacement for midwifery or medical clinical care. The below transcript was created with AI and may contain errors.

In most regions of the United States, RSV season starts in the fall and peaks in the winter. In September 2023, the ACOG released a Practice Advisory recommending a single dose of Pfizer's RSV vaccine (Abrysvo) for eligible pregnant individuals between 32 0/7 and 36 6/7 weeks of gestation who do not have a planned delivery within 2 weeks, using seasonal administration, to prevent RSV lower respiratory tract infection (LRTI) in infants. This is recommended from September to January. Currently, the US recommendation is for this to be given once, with subsequent deliveries receiving neonatal Beyfortus in RSV season. The recommendation from NICE is to have this vaccination with every pregnancy. The prescribing information for Abrysvo includes a warning to inform patients that a numerical imbalance in preterm births in Abrysvo recipients (5.7%) occurred compared to those who received placebo (4.7%). This imbalance was only seen in trial participants residing in low- to middle-income countries with no temporal association to vaccination or association with other adverse events in the mother or the newborn. Now, that phase 3 clinical data has gone through peer review and is a new publication. This is the MATISSE global study and will be officially published in the Green Journal February 2025…but we will summarize the results NOW in this episode! Listen in for details.

In episode 594, Mike and James invite Samantha Moe back to talk about the use of the RSV vaccine in pregnancy. The only way to have an informed conversation around this vaccine is to know the numbers. If you listen to the whole podcast, you'll get all the numbers available to date. Show notes Tools […]

I have bronchiectasis. Should I take the pneumonia and RSV vaccinations?A friend has hypersomnia and low sodium causing confusion and whole-body tiredness. Your thoughts?My husband has been getting a lot of bruising lately since starting Xarelto. Should he reduce his fish oil dose?I'm doing everything right and I still can't bring my blood pressure down.  What more can I do at 84?What are your thoughts on light therapy patches? Do they work? Are they safe to use? 

What are the statistics on vaccines? Are people getting vaccinated? What are common vaccines for children? Can kids get bird flu? Is it COVID season? AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses the latest trends in respiratory illnesses, what causes vaccine hesitancy and low seasonal vaccination rates for RSV, influenza and COVID-19. Also covering H5N1 in children, how bird flu spreads to humans and avian influenza symptoms in humans. American Medical Association CXO Todd Unger hosts.

Special guest Jean-Venable “Kelly” R. Goode, PharmD, BCPS, FAPhA, FCCP, Professor and Director of the Community-Based Residency Program at the Virginia Commonwealth University School of Pharmacy, join(s) us to talk about immunizations.Listen in as we discuss the latest COVID-19, influenza, and RSV vaccine recommendations and answer some common questions about giving vaccines.You'll also hear practical advice from TRC Editorial Advisory Board member, Stephen Carek, MD, CAQSM, DipABLM, the Program Director for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program and Clinical Associate Professor at the University of South Carolina School of Medicine, Greenville.For the purposes of disclosure, Dr. Goode reports relevant financial relationships [vaccines] with Pfizer, Valneva (honorarium). The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Chart: Flu Vaccines for 2024-25 (United States)Chart: COVID-19 Vaccines 2024-25 (United States)FAQ: Preventing RSVResource Hub: Immunization Resource HubIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

What are the new COVID vaccine guidelines? Is the RSV vaccine safe? When should you get the pneumococcal vaccine? Is there a vaccine for meningococcal disease? Our guest is Sandra  Fryhofer, MD, AMA's liaison to the Advisory Committee on Immunization Practices (ACIP) and a member of ACIP's COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts.

Join pediatrician Rachel Schultz, DO and Ob/Gyn Renda Knapp, MD as they discuss the RSV vaccine for babies and pregnant women. Why is this vaccine important? What is the difference between the vaccine for babies and the one for women? Learn about why RSV is dangerous for babies in particular.

Parents of young babies are citing confusion and concern following the recent introduction of the new RSV immunisation to babies, says pharmacist and healthcare advocate from the Wondercare podcast Sheena Mitchell.

Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD by Gastroenterology Learning Network

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.This week's commercialization news includes updates on Zepbound supply, Enjaymo's new home, and expanding access to HIV drugs. Medicare has tweaked rules for drug price talks, while GSK reports that its RSV vaccine protects against disease over three seasons. GSK's Viiv plans to expand the supply of HIV drugs in Africa, and Sanofi's rare disease drug finds a new home at Recordati. Other news includes a protein prediction winning the Chemistry Nobel and Alnylam submitting an important drug application. Trends suggest that biosimilars may make a mark in 2025, with incentives favoring them in the Medicare market. Protein prediction wins the Chemistry Nobel Prize, Alnylam submits a crucial drug application, Lilly partners with AI specialist Insitro to develop metabolic medicines, and Purespring raises $105 million for gene therapy for kidney disease. AI startup Basecamp allies with The Broad Institute to create 'programmable' genetic medicines. Additionally, Lilly appoints Mount Sinai scientist Thomas Fuchs as its first Chief AI Officer to lead AI initiatives in drug discovery and clinical trials. Other news includes J&J closing a cancer study, Alnylam seeking approval for a potential blockbuster drug, and Propharma receiving a regulatory and compliance award at CPhI.The Supreme Court declined to review a Texas abortion case related to emergency care, a blow to the Biden administration's efforts. A survey found that nearly 70% of healthcare organizations affected by cyberattacks experienced disruptions in patient care. Steward Health Care is auctioning off assets, including closing Norwood Hospital in Massachusetts. Baxter reported no structural damage at their North Carolina site affected by Hurricane Helene. The payer-provider relationship in healthcare is becoming more complex with consolidation and value-based care, leading to tensions over reimbursement and access.Kezar's lupus trial has been put on hold after four patient deaths, making it a potential buyout target. Investor Kevin Tang is interested in acquisition. Big pharma is also investing in cell and gene therapies, with companies like Lilly and Sanofi making moves in the industry. The Genscript Biotech Global Forum 2025 is coming up on January 15, offering a platform to discuss innovations and challenges in gene and cell therapy. Additionally, Lilly's obesity clinical program faces challenges, while Stealth's ultrarare disease candidate may not meet approval standards.Eli Lilly's obesity program is highlighted as a key factor in the company's dominance in the industry, with CEO David Ricks confident in their position. Wuxi Biologics faces uncertainty in the U.S. after setbacks, while big pharma companies show growing interest in cell and gene therapy. Five radiopharma biotechs are identified as potential buyout targets, and Trilink Biotechnologies introduces custom sets of mRNA for screening studies. Other news includes increased investment in cell and gene therapy, activist investor Starboard's stake in Pfizer, and Merck's success with Keytruda in head and neck cancer. AstraZeneca puts $2 billion towards heart disease drugs, Sanofi offloads a rare autoimmune drug, and AbbVie trims earnings guidance.

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk about the latest health news. Dr. Marty explains why cases of whooping cough are up in Illinois and who is at high risk of contracting it. She also talks about who should get their RSV vaccine and whether […]

Cold and flu season is not far off, but right now, new parents need to be aware of another respiratory virus called RSV. Almost all children will get it during their first two years, and thousands will have serious complications.Now, a new FDA-approved vaccine can protect your baby, even before the little one is born.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Aug. 28, 2024 - State Health Commissioner Jim McDonald talks about the state's ongoing effort to make the RSV vaccine more accessible for pregnant women and senior citizens.

Dr Eamonn O'Moore, Director of the HSE National Health Protection Office

How bad is COVID right now? Are COVID vaccines still free? Is there an mpox outbreak in Africa? RSV vaccine for seniors: What are the CDC guidelines for RSV in 2024? Our guest is American Medical Association Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. AMA CXO Todd Unger hosts.

RSV season is just around the corner (Fall and Winter months). Newborns are 16x more likely to be hospitalized with serious RSV lung infection than the flu. On August 21, 2023, the FDA approved the first RSV vaccine, Abrysvo, for use in pregnant individuals to protect newborns and infants against severe RSV disease in the first 6 months after birth. The FDA approved the vaccine to be administered between 32 and 36 weeks and 6 days of gestation. Then, on September 22, 2023, the CDC's Advisory Committee on Immunization Practices (ACIP) voted to recommend a single dose of maternal RSV vaccination for pregnant people at 32 through 36 weeks of gestation, using seasonal administration, to prevent RSV lower respiratory tract infection (LRTI) in infants.This resulted in the ACOG's endorsement, also in September 2023, of Abrysvo in pregnancy. However, the clinical trial resulting in the vaccine's FDA approval noted “a numerical imbalance” for preterm birth occurrence (1% more) in vaccine recipients. Because of this, there was a call for additional “real world outcomes“ to see if this finding would be replicated outside of the trial. In this episode, we will summarize a brand new (July 8, 2024) publication from JAMA Network Open which provides this data, although some noteworthy study limitations must be acknowledged. Listen in for details!

Dr Carol Blackburn is a Consultant in Emergency Medicine & Practices primarily in CHI at Crumlin

Health Minister Stephen Donnelly will today seek Cabinet approval for a vaccination programme for infants this autumn for Respiratory Syncytial Virus or more commonly known as RSV Speaking to Johnathan this morning was Dr. Brendan O'Shea, Kildare GP & Assistant Adjuvant Professor in Public Health and Primary Care at Trinity College Dublin.

Two glucose monitoring systems have been cleared for over-the-counter sale; Arexvy gains approval for adults aged 50 to 59 years; Kevzara approved for active polyarticular juvenile idiopathic arthritis; Generic Duchenne muscular dystrophy drug is made available; and Iqirvo gets accelerated approval for primary biliary cholangitis.

First generics of heart failure drug gain approval; mRNA vaccine approved for RSV; CDC make drug recommendation for STI prevention; Advisory Committee vote on MDMA for PTSD; Rinvoq approval expanded

In this episode, Angela Branche, MD, FIDSA, and Jewel Mullen, MD, MPH, MPA, FACP, address commonly asked questions about the RSV vaccine, including:Considerations for vaccine eligibilityRecommendations for pregnant personsVaccine administration based on RSV seasonalityUse of the vaccine in persons receiving immunosuppressive medicationsSafety data (eg, risk of serious adverse events)Natural immunity of RSVVaccine cost and insurance coverageFaculty:Angela Branche, MD, FIDSAAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkJewel Mullen, MD, MPH, MPA, FACPAssociate Dean for Health EquityAssociate Professor of Population Health and Internal MedicineUniversity of Texas at Austin Dell Medical SchoolAustin, TexasContent based on a CME program supported by an educational grant from GlaxoSmithKline.Follow along with a downloadable slideset at:https://bit.ly/44vCnFuLink to full program: https://bit.ly/3WvSY9ZTo get access to all of our new podcasts, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Angela Branche, MD, FIDSA, explores the burden of RSV disease in older adults, including:RSV seasonality and disease burdenSymptoms and complications of RSV infectionOlder age as a key risk factor for severe RSV disease and complications (eg, pneumonia, hospitalization)Comorbidities associated with increased risk of RSV hospitalizationRSV hospitalization rates among different racial and ethnic minority groups and socioeconomic statuses Faculty:Angela Branche, MD, FIDSAAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of MedicineUniversity of RochesterRochester, New YorkContent based on a CME program supported by an educational grant from GlaxoSmithKline.Follow along with a downloadable slideset at: https://bit.ly/44vCnFuLink to full program: https://bit.ly/3WvSY9ZTo get access to all of our new podcasts, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify

In this episode, Jewel Mullen, MD, MPH, MPA, FACP, discusses strategies for implementing RSV vaccines into practice, with an emphasis on:Understanding the reasoning for Advisory Committee on Immunization Practices RSV vaccine recommendations Factors that influence vaccine uptake and patient decision-makingConsiderations for patient and healthcare professional vaccine hesitancy Building vaccine confidence in both patients and healthcare professionalsUsing shared decision-making models (eg, SHARE approach)Faculty:Jewel Mullen, MD, MPH, MPA, FACPAssociate Dean for Health EquityAssociate Professor of Population Health and Internal MedicineUniversity of Texas at Austin Dell Medical SchoolAustin, TexasContent based on a CME program supported by an educational grant from GlaxoSmithKline.Follow along with a downloadable slideset at:https://bit.ly/44vCnFuLink to full program:https://bit.ly/3WvSY9ZTo get access to all of our new podcasts, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this Healthed lecture, Associate Professor Michael Woodward provides an update on what is now known about the RSV virus in Australia as well as advising what is coming in terms of prevention and treatment of RSV, including vaccines which it is hoped will soon become available for those vulnerable to severe RSV infection.See omnystudio.com/listener for privacy information.

For years, Kelley has been searching for a holistic pediatrician for her kids, and while she doesn't live in Vegas Kelley and Chad get the pleasure of sitting down with integrative pediatrician Dr. Ana Maria Temple today on the show to learn all about the real cause of chronic health conditions in our children. Dr. Temple started her practice as a typical Western pediatric doctor, but when she began to see chronic conditions popping up with her own kids, she knew she had to make a change and better understand what was going on from a root cause perspective. Through her journey of healing her own children when it came to chronic ear infections, asthma, ADD and eczema and her travels to living in New Zeland and discovering a lifestyle that was predicated on prevention, Dr. Temple completely switched her approach to medicine where her mission is now to help families implement positive changes in their lifestyle so that they can achieve a better quality of life.Through their conversation, Kelley, Chad and Dr. Temple discuss the impact of the changes in the food industry in America in the last 50 years on the health of America's youth. The addition of these chemicals to our food has led to various health issues in children, including neurological problems, chronic conditions like asthma, eczema, allergies, and so much more. They discuss how to create change in your children's diets for better health (even in the pickiest eaters), the connection between gut health and chronic conditions like eczema and recurrent ear infections and the importance of positive reinforcement and quality time in rewarding behavior for kids. Finally, they unpack the controversial topic of vaccines: from when is the right timing, to which ones skip, and which are important to have as our children go out into society. Tune in to learn about how to holistically support your child and create an environment for their health and wellbeing to thrive.  To connect with Kelley click HERETo book a lab review with Kelley click HERE To connect with Dr. Temple click HERE 

SHOW NOTES: Today's BONUS EPISODE is an article from Children's Health Defense looking at the evidence behind the RSV shot and whether it is safe and effective for pregnant mothers and babies.   Helpful Links:   HOW TO WORK WITH LORI:   --> Sign up HERE for the Your Birth, God's Way Online Christian Childbirth Course! This is a COMPLETE childbirth education course with a God-led foundation taught by a certified nurse-midwife with over 20 years of experience in all sides of the maternity world Learn more or sign up HERE!       Get Christian pregnancy and birth merch HERE   Lori's Recommended Resources HERE   Sign up for email updates Here   Be heard! Take My Quick SURVEY to give input on future episodes you want to hear --> https://bit.ly/yourbirthsurvey   Got questions?  Email lori@yourbirthgodsway.com     Socials: Follow Your Birth, God's Way on Instagram! Follow the Your Birth, God's Way Facebook Page! Join Our Exclusive Online Birth Community -- facebook.com/groups/yourbirthgodsway   Learn more about Lori and the podcast at yourbirthgodsway.com!   FREE Bible Study Course - How To Be Sure Of Your Salvation       DISCLAIMER:  Remember that though I am a midwife, I am not YOUR midwife.  Nothing in this podcast shall; be construed as medical advice.  Listening to this podcast does not mean that we have entered into a patient-care provider relationship. While I strive to provide the most accurate information I can, content is not guaranteed to be 100% accurate.  You must do your research and consult other reputable sources, including your provider, to make the best decision for your own care.  Talk with your own care provider before putting any information here into practice.  Weigh all risks and benefits for yourself knowing that no outcome can be guaranteed.  I do not know the specific details about your situation and thus I am not responsible for the outcomes of your choices.    Some links may be affiliate links which provide me a small commission when you purchase through them.  This does not cost you anything at all and it allows me to continue providing you with the content you love.

When did COVID start in the US? Should I take Paxlovid? What is the COVID death toll? Where is the measles outbreak? Is measles eliminated in the US? What is the RSV vaccine recommendations for children? Our guest is AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. American Medical Association CXO Todd Unger hosts.

Visit nascentmc.com/podcast for full show notes [free course] ChatGPT4 in medical writing and editing at learnAMAstyle.com Nascentmc.com for medical writing assistance for your CME or Medical Communications company. Eplontersen for ATTR-CM Eplontersen received FDA Fast Track designation for treating transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) in adults, aiming to inhibit TTR protein production. Nivolumab for NSCLC The FDA accepted supplemental applications for nivolumab in resectable stage 2A to 3B non-small cell lung cancer (NSCLC) based on the CheckMate-77T trial showing improved survival rates. RSV Vaccine for Adults Aged 50 to 59 The FDA prioritizes review of GSK's Arexvy vaccine for RSV in adults aged 50-59 at risk of complications, expanding from its existing approval for those 60 and older. Spinal Cord Stimulation System The FDA approved Boston Scientific's WaveWriter Spinal Cord Stimulation Systems for chronic low back and leg pain treatment in non-surgery patients, based on the SOLIS trial results. OK-101 for Neuropathic Corneal Pain The FDA approved an IND application for OK-101, a first for treating neuropathic corneal pain (NCP), an Orphan disease, developed by OKYO Pharma Limited. Viz ICH Plus for Brain Bleed The FDA cleared Viz ICH Plus, an AI algorithm by Viz.ai for automating the identification and quantification of brain bleeds and structures in NCCT images. Vepdegestrant for MBC Vepdegestrant received FDA Fast Track designation for treating ER-positive/HER2-negative advanced or metastatic breast cancer in patients previously treated with endocrine therapy. VerTouch Spinal Puncture Device The FDA cleared VerTouch, a handheld imaging tool by IntuiTap Medical, designed to improve the accuracy of spinal punctures by providing a 2D image of lumbar spinal anatomy.

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about Elon Musk’s Neuralink implanting a brain chip in the first human patient, the latest research on helping long COVID sufferers, the efficacy of the RSV vaccine, who should be getting the RSV vaccine, the amount of people in Chicago […]

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about Elon Musk’s Neuralink implanting a brain chip in the first human patient, the latest research on helping long COVID sufferers, the efficacy of the RSV vaccine, who should be getting the RSV vaccine, the amount of people in Chicago […]

Were the 'hunters' in hunter-gatherer societies always men? No! Learn about it from Mary Williams. Then, hear about the 12,000-year-old flutes that might have been used for hunting. Then, Scott Miller fills us in on what planets, constellations, nebulae, and star clusters we can see in the night sky in February. Finally, Dave Robinson discusses the recent development of vaccines that can protect people from the dangerous Respiratory Syncytial Virus (RSV). ‘Bench Talk: The Week in Science' is a weekly radio program that airs on WFMP Louisville FORward Radio 106.5 FM (forwardradio.org) every Monday at 7:30 pm, Tuesday at 11:30 am, and Wednesday at 7:30 am. Visit our Facebook page for links to the articles discussed in this episode: https://www.facebook.com/pg/BenchTalkRadio/posts/?ref=page_internal Music ('Marimba on the Hunt' by Daniel Birch) is provided by freemusicarchive.org.

Del takes a deep dive on the newly approved RSV vaccine's side effects on pregnant women. Using data straight from ABRYSVO's own box insert for data, he highlights the increased risk of preterm birth and buffer ingredients such as polysorbate 80 and residual DNA from host cell proteins from Chinese hamster cell lines. Does this sound safe to you?

A check-in on COVID, flu and RSV cases, and an overview of new COVID and Long Covid studies. AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, reports that the tripledemic wave is declining, but vaccination levels for COVID, flu and RSV among adults are still low. Plus, continued supply issues for the RSV vaccine for children, administration errors for the RSV vaccine, and two new studies that could inform future treatments for COVID and Long COVID. American Medical Association CXO Todd Unger hosts.

In today's episode Drs. Cocuzzo and Anokwte discuss the new RSV vaccine, childhood obesity as a chronic illness, how to deal with fevers, and social media usage among adolescence.  Time Stamps:  Health News - 1:48 Childhood Obesity - 4:23  Parenting Tip - 11:45  Social Media - 16:04 Trivia - 22:13

Nirsevimab is the new FDA-approved monoclonal antibody RSV vaccine for the prevention of severe lower respiratory illness in infants. In this episode, we discuss the current recommendations on who gets the vaccine and when, how to use a lens of health equity to approach the current vaccine shortages, and how to discuss safety and efficacy with vaccine hesitant parents. Now that nirsevimab is on the routine infant immunization schedule, it's extremely important and pediatric providers understand the recommendations and science behind the monoclonal antibody to help vaccine acceptance that will undoubtedly reduce bronchiolitis hospitalization. Instagram: @thepedsnppodcast Show notes and references thepedsnp.com Disclaimer   References: CDC Health Alert Network. (2023). Limited availability of nirsevimab in the United States—Interim CDC recommendations to protect infants from Respiratory Syncytial Virus (RSV) during the 2023–2024 respiratory virus season. Emergency Preparedness and Response. https://emergency.cdc.gov/han/2023/han00499.asp?c Centers for Disease Control and Prevention. (2023). Frequently asked questions about RSV immunization with monoclonal antibody for children 19 months and younger. Vaccines and Preventable Diseases. https://www.cdc.gov/vaccines/vpd/rsv/hcp/child-faqs.html Centers for Disease Control and Prevention. (2022). Vaccines for Children Program. https://www.cdc.gov/vaccines/programs/vfc/index.html Centers for Disease Control and Prevention. (2023). General best practice guidelines for immunization. Vaccine Recommendations and the Guidelines of the ACIP. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html Jones, J. M., Fleming-Dutra, K. E., Prill, M. M., Roper, L. E., Brooks, O., Sánchez, P. J., Kotton, C. N., Mahon, B. E., Meyer, S., Long, S. S., & McMorrow, M. L. (2023). Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR. Morbidity and mortality weekly report, 72(34), 920–925. https://doi.org/10.15585/mmwr.mm7234a4 Hill, D., & Parga-Belinkie, J. (Host). (2023, August 29). Immunizations special: RSV, Covid, pneumococcal disease, influenza (No. 170) [Audio podcast episode]. In Pediatrics on call. American Academy of Pediatrics. www.aap.org/podcast Rha, B., Curns, A. T., Lively, J. Y., Campbell, A. P., Englund, J. A., Boom, J. A., Azimi, P. H., Weinberg, G. A., Staat, M. A., Selvarangan, R., Halasa, N. B., McNeal, M. M., Klein, E. J., Harrison, C. J., Williams, J. V., Szilagyi, P. G., Singer, M. N., Sahni, L. C., Figueroa-Downing, D., McDaniel, D., … Gerber, S. I. (2020). Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics, 146(1), e20193611. https://doi.org/10.1542/peds.2019-3611 Suh, M., Movva, N., Jiang, X., Bylsma, L. C., Reichert, H., Fryzek, J. P., & Nelson, C. B. (2022). Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample. The Journal of infectious diseases, 226(Suppl 2), S154–S163. https://doi.org/10.1093/infdis/jiac120

Newborn babies and infants are particularly vulnerable to the respiratory virus RSV, but Health Canada has approved a vaccine that can be given during pregnancy. Pediatrician Dr. Jesse Papenburg explains how it might keep kids out of hospital in the earliest days of their lives.

KSQD 12-20-2023: Cold weather increases the tendency to have atrial fibrillation; Help interpreting an abdominal ultrasound; Should my wife and I get the RSV vaccine? Brain implant device greatly improves mental skills in traumatic brain injury patients; Singing to your baby helps develop language development; Recalling memories as therapy for PTSD and other brain problems; Medical alert for hair products that or toxic only when heated; Deep dive into the immune system's involvement in postpartum depression; Stimulation in the vagus nerve to help stroke recovery and Parkinson's disease; Baby talk by parents to their infants is universal; Take breaks and walk if you have to sit long hours each day

Dr. Jim McDonald, Commissioner of Health, New York State Department of Health, gives an order that allows New York pharmacists to administer RSV vaccines to older adults and pregnant people without a prescription; de Beaumont President and CEO Dr. Brian Castrucci says the book he edited with ASTHO CEO Dr. Mike Fraser, Building Strategic Skills for Better Health, is a must-read for every new or current public health professional; ASTHO plans a webinar to tell you how to improve access to emergency contraception; and sign up ASTHO's public health newsletters. New York State Department of Health Issues Standing Order to Allow Pharmacists to Administer RSV Vaccines to Older Adults without a Prescription ASTHO Webpage: Building Strategic Skills for Better Health ASTHO Webinar: Provider Strategies to Improve Access to Emergency Contraception ASTHO Email Newsletters: Sign Up Here

An investigation was published recently in the British Medical Journal that outlined how Pfizer failed to disclose to pregnant women the risks that were potentially present in their vaccine trials.

Respiratory syncytial virus (RSV) is a common virus that can cause respiratory infections in people of all ages, including pregnant women. RSV infections are more prevalent during the fall and winter months. While RSV infections are usually mild and cold-like in healthy adults, they can lead to more severe respiratory symptoms in certain populations, including young infants and individuals with weakened immune systems. In the context of pregnancy, RSV infections are generally considered a concern primarily because of the potential impact on the health of the mother and the developing fetus. Here are some key points to consider regarding RSV in pregnancy: Risks to the Pregnant Woman: Pregnant women may be at a slightly increased risk of developing severe RSV-related symptoms compared to non-pregnant individuals. Symptoms of an RSV infection in adults can include fever, cough, congestion, and shortness of breath. Severe cases may require hospitalization. Risks to the Fetus: RSV infections in pregnant women do not typically cause direct harm to the fetus, such as birth defects. However, severe respiratory infections in the mother can potentially reduce the oxygen supply to the fetus, which could be problematic in rare cases. There is some evidence to suggest that maternal RSV infection may be associated with an increased risk of preterm birth. Prevention: Pregnant women can take steps to reduce their risk of RSV infection, such as practicing good hand hygiene, avoiding close contact with individuals who are sick, and following respiratory etiquette (covering mouth and nose when coughing or sneezing). There is a medication called palivizumab (Synagis) that can be given to certain high-risk infants to help prevent severe RSV disease, but it is not typically recommended for pregnant women. Treatment: Treatment for RSV infection in pregnant women is generally supportive, focusing on managing symptoms and maintaining adequate hydration. Pregnant women with severe symptoms may require hospitalization for oxygen therapy and other interventions. It's important for pregnant women to consult with their healthcare providers if they develop symptoms of a respiratory infection like RSV, especially if the symptoms are severe or persistent. Healthcare professionals can provide guidance on appropriate management and treatment. As with any health concern during pregnancy, it's essential to follow the advice and recommendations of your healthcare provider to ensure the health and well-being of both the mother and the developing fetus.   Your feedback is essential to us! We would love to hear from you. Please consider leaving us a review on your podcast platform or sending us an email at info@maternalresources.org. Your input helps us tailor our content to better serve the needs of our listeners. For additional resources and information, be sure to visit our website at Maternal Resources: https://www.maternalresources.org/. You can also connect with us on our social channels to stay up-to-date with the latest news, episodes, and community engagement: Twitter: https://twitter.com/integrativeob YouTube: https://www.youtube.com/maternalresources Instagram: https://www.instagram.com/integrativeobgyn/ Facebook: https://www.facebook.com/IntegrativeOB Thank you for being part of our community, and until next time, let's continue to support, uplift, and celebrate the incredible journey of working moms and parenthood. Together, we can create a more equitable and nurturing world for all.

Join us as we review recent practice-changing articles on VKAs vs DOACs in frail adults with atrial fibrillation, RSV vaccine for adults over 60, how much does blood pressure cuff size matter, cotton fever in people who inject drugs, new bloating and belching guidelines, and does pip-tazo cause more AKI than cefepime. Fill your brain hole with a delicious stack of hotcakes! Featuring Paul Williams (@PaulNWilliamz), Rahul Ganatra (@rbganatra), and Matt Watto (@doctorwatto). Claim CME for this episode at curbsiders.vcuhealth.org! Episodes | Subscribe | Spotify | Swag! |Mailing List | Contact | CME! Credits Written and Hosted by: Rahul Ganatra MD, MPH; Paul Williams, MD, FACP, Matthew Watto MD, FACP Cover Art: Matthew Watto MD, FACP Reviewer: Sai Achi, MD Technical Production: Pod Paste Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Show Segments Intro, disclaimer VKAs vs DOACs in frail adults with atrial fibrillation,  RSV vaccine for adults over 60,  how much does blood pressure cuff size matter? cotton fever in people who inject drugs,  new bloating and belching guidelines, does pip-tazo cause more AKI than cefepime? Outro Sponsor: Pathway  Download the Pathway app for free today. Sponsor: Locumstory  Get a comprehensive view of locums and decide if it's right for you at locumstory.com.

Dr. Marcus Plescia, ASTHO Chief Medical Officer, wants public health to focus on medical providers as the primary way to promote the RSV vaccine; an ASTHO blog article explains why public health readiness during the respiratory virus season is key; an ASTHO blog article outlines how to use data to better understand the vaccine opinion landscape; and Dr. Kris Bryant, a healthcare epidemiologist at Norton Children's Hospital, says the American Academy of Pediatrics is working to make it known that health disparities exist when it comes to influenza. ASTHO Blog Article: Policymakers Boosting Public Health Readiness for Respiratory Illness Season ASTHO Blog Article: Using Data and Effective Messaging to Support Strong Vaccine Policy American Academy of Pediatrics Webpage: Recommendations for Prevention and Control of Influenza in Children, 2023–2024 Healthy Children Webpage: Which Flu Vaccine Should Children Get? ASTHO Webpage: Stay Informed  

Israel's defense minister says troops are preparing to attack Hamas by "air, ground and sea". Meanwhile, aid agencies are calling for a ceasefire in Gaza. House Republicans will vote in a secret ballot to select their next candidate for speaker. The CDC says there may not be enough supplies of some RSV vaccines. Plus, a Washington state senator has been arrested and released on bail in Hong Kong.To learn more about how CNN protects listener privacy, visit cnn.com/privacy

We have been following this developing story on the Maternal RSV vaccine, Abrysvo. In the recent podcast, we stated that we would let you know when the ACOG releases its “Practice Advisory”, which is its clinical guidance update. This is now out! In this episode will provide the summary, high-yield points regarding this vaccine's use in pregnancy. Can this be co-administered with other vaccines? What did ACOG say about the preterm birth “numerical imbalance” among study trial participants who received this vaccine? And which option provides a stronger and longer lasting immune response in the child: maternal vaccination, or newborn vaccination? Listen in and find out.

Happy Wednesday! The RSV Vaccine is approved for pregnant women. The Republican debate is tonight. No Copyrights for AI works. The military might allow calculators for entrance exams. Paris bans pony rides. Sign up to play Two-Second Tunes or Cover Lovers  https://forms.gle/Bf6aPVTbEqmo4QoS6 NEWSLETTER ⬅️ BLITZ: KICKS4KIDS What's Trending:https://www.goodreads.com/ Head to TheMorningShowPodcast.com for EVERYTHING we talk about. Seattle Gummy Company - code: CMA for 20% off https://seattlegummy.com/?ref=802 QUICK LINKS TO WATCH US LIVE, SUBSCRIBE TO NEWSLETTER, FOLLOW OUR SOCIALS HERE: https://www.flowcode.com/page/carlamarieandanthony Follow Carla Marie on Instagram Follow Anthony on InstagramSee omnystudio.com/listener for privacy information.

A daily non-partisan, conversational breakdown of today's top news and breaking news stories.  This Week's Sponsors:  – Athletic Greens – AG1 Powder + 1 year of free Vitamin D & 5 free travel packs – Shopify – $1 per-month trial Code: monews – WeWork – 20% Off Your First 6 Months | CODE: MOWORKS20  Headlines: – Hilary Floods Roadways in California. Next Up: Oregon and Idaho (02:45) – Keeping An Eye On Tropical Storm Harold in Texas (04:00) – Biden's Visit Maui To Mixed Reception (04:25) – FDA Approves First RSV Vaccine Given To Pregnant Mothers To Protect Babies (06:10) – Health Officials Tracking Three New Covid Variants (08:00) – Trump Faces $200K Bond, Orders Not To Send Threatening Social Messages in GA (13:30) – Gun Deaths Among Children In The US Hits New High (17:20) – Manufacturing Boom In The US (19:10) – Spanish Soccer Chief Facing Backlash For Kissing Player On Mouth (21:05) – Rihanna Welcomes Second Baby With ASAP Rocky (23:55) – On This Day In History (26:20) **Mo News Premium For Members-Only Instagram, Private Podcast: (Click To Join)** — Mosheh Oinounou (@mosheh) is an Emmy and Murrow award-winning journalist. He has 20 years of experience at networks including Fox News, Bloomberg Television and CBS News, where he was the executive producer of the CBS Evening News and launched the network's 24 hour news channel. He founded the @mosheh Instagram news account in 2020 and the Mo News podcast and newsletter in 2022. Jill Wagner (@jillrwagner) is an Emmy and Murrow award- winning journalist. She's currently the Managing Editor of the Mo News newsletter and previously worked as a reporter for CBS News, Cheddar News, and News 12. She also co-founded the Need2Know newsletter, and has made it a goal to drop a Seinfeld reference into every Mo News podcast. Follow Mo News on all platforms: Instagram: https://www.instagram.com/mosheh/ Twitter: https://twitter.com/mosheh Facebook: https://www.facebook.com/MoshehNews Snapchat: https://t.snapchat.com/pO9xpLY9 Youtube: https://www.youtube.com/@monews TikTok: https://www.tiktok.com/@mosheh Learn more about your ad choices. Visit megaphone.fm/adchoices